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Although respiratory tract infections can be a common complication in peoplewith Parkinson’s disease (PD), there is little published
data on the nature of such infections in this patient group.Wewished to investigate whether sputum samples were being taken from
PD patients in order to establish whether an infection was present and if so which bacteria were responsible for the infection. We
recorded the number of positive sputum samples taken from admission to North Tyneside General Hospital in North-East England
across a ten-year period from June 2001 to June 2011. Of 643 in-patient episodes involving people with PD, positive sputum samples
were recorded for only 12 episodes (1.9%) in eight patients. All patients were in early stage disease. In all admissions to theNHSTrust
running the hospital, there were 23,069 sputum cultures from 1,056,693 in-patient episodes (2.2%). Our findings may reflect the
difficultly of expectorating inmany people with PD, particularly in late-stage disease. Since people with PD are especially vulnerable
to respiratory tract infections, clinicians need to ensure that, where possible, a sputum sample is obtained from people with PD
when clinically indicated.
1. Introduction
Respiratory tract infections can be a common complication
in people with Parkinson’s disease (PD). Indeed, 45% of all
death certificates for people who had PD have pneumonia
listed as a cause of death, a greater proportion than that
seen in the general population [1]. The reasons for this are
likely to be multifactorial, with reduced mobility during late-
stage disease, swallowing difficulty, and impaired cough reflex
likely to play major roles [2, 3]. Respiratory dysfunction
has also been linked to swallowing problems in people with
PD [4]. Identifying the nature of respiratory tract infections
allows optimal patient care. As part of an audit within a UK
National Health Service (NHS) general hospital, we wished
to investigate how many sputum cultures were recorded for
people with PD. We hoped that this would act as a guide as
to how well such infections are monitored during in-patient
hospital visits.
2. Methods
The study was registered with Northumbria Healthcare
NHS Foundation Trust’s research department and approval
granted from the Caldicott Guardian. Ethical approval was
not required for this retrospective audit of patient’s notes.
Northumbria Healthcare NHS Foundation Trust pro-
vides acute care for a population of around 500,000 people
in northeast England.
The trust runs three general hospitals including North
Tyneside General Hospital which covers a population of
around 200,000 people. The trust’s PD service cares for
around 700 people with PD within its catchment area. The
vast majority of people with PD in the catchment area are
served by the trust [5, 6].Microbiology archives and a register
of people with PD cared for by the PD team at North
Tyneside General Hospital were used to locate PD patients
with positive sputum cultures during the ten-year period
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from June 2001 to June 2011. PD diagnosis was according to
theUKBrain BankCriteria. Organismwas noted and the case
notes were reviewed for clinical details.
Trustwide data were also obtained regarding the number
of positive sputum cultures within the entire trust and the
total number of in-patient episodes (elective, nonelective, and
day cases) during the period.
3. Results
Of 643 in-patient episodes at North Tyneside General
Hospital involving people with PD during the ten-year
study period, only 12 (1.9%) positive sputum samples (in
eight patients) were recorded. Within the trust, there were
1,056,693 in-patient episodes over this period and 23,069
(2.2%) positive sputum cultures.
One patient had three positive samples and two patients
had two positive samples during a single in-patient stay.
Seven of the eight patients were male and all were in early
stage disease at the time of their stay (two having Hoehn and
Yahr stage I, three having Hoehn and Yahr stage II, and three
having Hoehn and Yahr stage III).
Eight different types of organisms were detected, includ-
ing S. aureus (𝑛 = 3), H. influenzae (𝑛 = 3), coliform (𝑛 = 2),
C. albicans (𝑛 = 2), S. pneumoniae (𝑛 = 2), E. coli (𝑛 = 1),
Haemophilus sp. (𝑛 = 1), and M. catarrhalis (𝑛 = 1). Two
patients had multiple organisms.
4. Discussion
Pneumonia is a common complication in people with PD,
particularly in later-stage disease. In a study from 2005 by
members of our team, pneumonia was responsible for 11.4%
of all emergency hospital admissions and was the second
most common cause of admission after falls [7]. A more
recent UK-wide study of elective and nonelective hospital
admissions supports these findings [8]. The authors found
pneumonia to be the leading cause of admission in people
with PD during a four-year period from 2009 to 2013,
with 13.5% of 232,905 emergency PD admissions due to
pneumonia. In the general population aged 35 years and over,
pneumonia was responsible for only 7.0% of admissions.
Given the fact that pneumonia appears to be more
common in people with PD than the general population,
there were remarkably few positive sputum samples during
the ten-year period of our study [7]. Indeed, since pneumonia
is generally more common in older age, the fact that a greater
percentage of all admissions across all age groups had a
sputum sample taken than did people with PD is notable.
Further analysis of these data is hampered by the small
number of positive sputum cultures found. A larger, prospec-
tive study is merited. Interestingly, all of the samples were
in people with early stage PD; this may reflect the difficulty
of those in later-stage disease to expectorate and may be
the main reason why so few positive cultures were found.
Indeed, thosewhohad positive sputumcultureswere ofmuch
earlier disease stage than typically seen for hospital in-patient
admissions in people with PD, suggesting that this may well
be the case [7, 9]. Chest infection is reported as one of the
most common reasons for hospital admission of people with
PD [7, 9]. Swallowing difficultly, a well-recognised symptom
of PD that increases in later stages, is likely to be partly
responsible for this [2, 4].
Although obtaining a sputum sample from someone in
mid- to late-stage disease may be difficult, all patients admit-
ted to hospital with respiratory symptoms should, where
physically possible, have a sputum sample taken to ensure
appropriate and effective treatment. Future prospective
research should investigate if enough is being done to obtain
such samples and suggest what measures can be put in place
to ensure that, where possible, samples are obtained. Greater
involvement of physiotherapists in the care of hospitalised PD
patients may be a useful starting point for any intervention
and is recommended in recent European guidelines on the
role of physiotherapy for people with PD [10].
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